Brendan Hannah, Chief Business Officer and COO: Quince Therapeutics QNCX Buy · Filed 24/08/21

Trade details

Type: Insider buy
Amount: $14,845.95
Shares · price: 23,565 sh · $0.63 a share
Held after: 296,540 sh
Stock: Quince Therapeutics QNCX
Person: Brendan HannahChief Business Officer and COO
Trade date: 24/08/21
Filed: 24/08/21
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +8.6%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

Brendan Hannah's recent trades

Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,391
2,280 sh
$1,391
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$2,054
3,424 sh
$2,054
Filed 24/08/21
Traded 24/08/20
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$3,100
5,000 sh
$3,100
Filed 24/08/21
Traded 24/08/21
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,250
2,155 sh
$1,250
Filed 24/08/21
Traded 24/08/19
Brendan HannahChief Business Officer and COO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$1,525
2,500 sh
$1,525
Filed 24/08/21
Traded 24/08/20

Brendan Hannah, COO — bought $14.8K of Quince Therapeutics QNCX · 23,565 sh @ $0.63 | Whalegun